3 Smartest Dividend Stocks to Buy Now
When the market entered a correction in February and March,…
Buy
67
SYF Quote, Financials, Valuation and Earnings
Last price:
$53.22
Seasonality move
:
4.95%
Day range:
$50.85 - $53.13
52-week range:
$39.67 - $70.93
Dividend yield:
1.89%
P/E ratio:
6.20x
P/S ratio:
1.41x
P/B ratio:
1.34x
Volume:
6.1M
Avg. volume:
4.8M
1-year change:
22.77%
Market cap:
$20.6B
Revenue:
$16.1B
EPS (TTM):
$8.54
Analysts' Opinion
-
Consensus RatingSynchrony Financial has received a consensus rating of Buy. The company's average rating is a Buy based on 9 Buy ratings, 7 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $75.52, Synchrony Financial has an estimated upside of 42.66% from its current price of $52.94.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $57.00 representing -7.67% downside risk from its current price of $52.94.
Fair Value
-
According to the consensus of 16 analysts, Synchrony Financial has 42.66% upside to fair value with a price target of $75.52 per share.
SYF vs. S&P 500
-
Over the past 5 trading days, Synchrony Financial has underperformed the S&P 500 by -3.46% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Synchrony Financial does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Synchrony Financial has grown year-over-year revenues for 13 quarters straight. In the most recent quarter Synchrony Financial reported revenues of $3.8B.
Earnings Growth
-
Synchrony Financial has grown year-over-year earnings for 4 quarters straight. In the most recent quarter Synchrony Financial reported earnings per share of $1.91.
Enterprise value:
19.5B
EV / Invested capital:
--
Price / LTM sales:
1.41x
EV / EBIT:
2.12x
EV / Revenue:
1.29x
PEG ratio (5yr expected):
0.10x
EV / Free cash flow:
1.98x
Price / Operating cash flow:
2.15x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
2.93%
Net Income Margin (TTM):
23.24%
Return On Equity:
22.64%
Return On Invested Capital:
11.21%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $11.7B | $13.6B | $15.1B | $3.7B | $3.8B | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | $6.10 | $5.18 | $8.54 | $1.03 | $1.91 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $19B | $13.6B | $15.2B | $18.1B | $17.8B | |
| Total Assets | $95.9B | $95.7B | $104.6B | $117.5B | $119.5B | |
| Current Liabilities | -- | -- | -- | -- | -- | |
| Total Liabilities | $83.2B | $82.1B | $91.7B | $103.6B | $102.9B | |
| Total Equity | $12.7B | $13.7B | $12.9B | $13.9B | $16.6B | |
| Total Debt | $15.8B | $14.5B | $14.2B | $16B | $15.5B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $6.7B | $8.6B | $9.8B | $2.3B | $2.4B | |
| Cash From Investing | -$10.2B | -$14.2B | -$8.9B | -$7.2B | -$5B | |
| Cash From Financing | $5.3B | $9.6B | -$611M | $3.5B | -$617M | |
| Free Cash Flow | $6.7B | $8.6B | $9.8B | $2.3B | $2.4B | |
SYF
Sector
Market Cap
$20.6B
$614.3M
Price % of 52-Week High
74.64%
85.46%
Dividend Yield
1.89%
1.98%
Shareholder Yield
5.35%
3.73%
1-Year Price Total Return
22.77%
7.6%
Beta (5-Year)
1.455
0.558
Dividend yield:
1.89%
Annualized payout:
$1.00
Payout ratio:
13.43%
Growth streak:
3 years
Technicals
8-day SMA
Sell
Level
$54.29
200-day SMA
Sell
Level
$56.08
Bollinger Bands (100)
Sell
Level
57.89 - 68.77
Chaikin Money Flow
Sell
Level
-36.9M
20-day SMA
Sell
Level
$54.25
Relative Strength Index (RSI14)
Sell
Level
37.57
ADX Line
Sell
Level
41.77
Williams %R
Neutral
Level
-63.3975
50-day SMA
Sell
Level
$61.42
MACD (12, 26)
Sell
Level
-2.02
25-day Aroon Oscillator
Sell
Level
-80
On Balance Volume
Neutral
Level
284.3M
Financial Scores
--
Altman Z-Score
(Annual)
Level (--)
Sell
CA Score
(Annual)
Level (-1.7678)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (10)
--
Ohlson Score
Level (--)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Synchrony Financial, originally a spinoff of GE Capital's retail financing business, is the largest provider of private-label credit cards in the United States by both outstanding receivables and purchasing volume. Synchrony partners with other firms to market its credit products in their physical stores as well as on their websites and mobile applications. Synchrony operates through three segments: retail card (private-label and co-branded general-purpose credit cards), payment solutions (promotional financing for large ticket purchases), and CareCredit (financing for elective healthcare procedures).
Stock Forecast FAQ
In the current month, SYF has received 9 Buy ratings 7 Hold ratings, and 0 Sell ratings. The SYF average analyst price target in the past 3 months is $75.52.
-
Where Will Synchrony Financial Stock Be In 1 Year?
According to analysts, the consensus estimate is that Synchrony Financial share price will rise to $75.52 per share over the next 12 months.
-
What Do Analysts Say About Synchrony Financial?
Analysts are divided on their view about Synchrony Financial share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Synchrony Financial is a Sell and believe this share price will drop from its current level to $57.00.
-
What Is Synchrony Financial's Price Target?
The price target for Synchrony Financial over the next 1-year time period is forecast to be $75.52 according to 16 Wall Street analysts, 9 of them rate the stock a Buy, 0 rate the stock a Sell, and 7 analysts rate the stock a Hold.
-
Is SYF A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Synchrony Financial is a Buy. 9 of 16 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of SYF?
You can purchase shares of Synchrony Financial via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Synchrony Financial shares.
-
What Is The Synchrony Financial Share Price Today?
Synchrony Financial was last trading at $53.22 per share. This represents the most recent stock quote for Synchrony Financial. Yesterday, Synchrony Financial closed at $52.94 per share.
-
How To Buy Synchrony Financial Stock Online?
In order to purchase Synchrony Financial stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
How High Could IBIT Go?
Recently, a surprising number of billionaire hedge fund managers have…
Is Raymond James Stock a Buy, Sell or Hold?
Raymond James Financial (NYSE:RJF) is one of America’s large financial…
Stock Ideas
Buy
56
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Sell
41
Is NVDA Stock a Buy?
Market Cap: $2.6T
P/E Ratio: 37x
Alerts
Buy
80
CORT alert for Apr 1
Corcept Therapeutics [CORT] is down 15.95% over the past day.
Sell
16
PCVX alert for Apr 1
Vaxcyte [PCVX] is down 2.57% over the past day.
Sell
47
RGC alert for Apr 1
Regencell Bioscience Holdings [RGC] is down 3.39% over the past day.
